Medicus Pharma (NASDAQ: MDCX) has announced the appointment of Andrew Smith as chief operating officer (COO).
A seasoned leader in asset management and financial operations with more than three decades of experience, Mr. Smith most recently served as the chief executive of SR Asset Management (SRAM) until its sale in 2024. He currently sits on the board of HazelTree Fund Services and is an advisor to Code Registry.
“We are delighted to welcome Andrew to the leadership team,” Dr. Raza Bokhari, executive chairman and CEO of Medicus, said. “Andrew’s experience and expertise is very relevant and timely, as we expand our business and clinical development operations with active engagements in three continents.”
